| abstract |
The present invention relates to substituted heterocyclic derivative therapeutic compounds, compositions comprising the same, and compositions and compositions thereof for inhibiting the bromo structure of an amino acid-free amino acid region of a protein such as a tissue protein Domain-mediated recognition for the use of epigenetic regulation. Such compositions and methods are useful for treating diseases mediated by abnormal cell signaling, such as inflammatory conditions, cancer, and oncological diseases. |